Genetic association of Ctla-4 to myasthenia gravis with thymoma

This publication has 34 references indexed in Scilit:

• Is CTLA-4 a negative regulator for T-cell activation?
  Immunology Today, 1997
• Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
  The Journal of Experimental Medicine, 1996
• The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry
  Human Molecular Genetics, 1996
• Enhancement of Antitumor Immunity by CTLA-4 Blockade
  Science, 1996
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
  Science, 1995
• Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
  Immunity, 1995
• CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
  Journal of Clinical Endocrinology & Metabolism, 1995
• Myasthenia Gravis
  New England Journal of Medicine, 1994
• TheIL-1? and ? genes are closely linked (<70 kb) on mouse chromosome 2
  Somatic Cell and Molecular Genetics, 1990
• A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
  Cell, 1986